Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Catalent Appoints VP Finance, Investor Relations | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Catalent Appoints VP Finance, Investor Relations

Castellano to lead investor relations efforts

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Thomas Castellano has been appointed vice president finance, investor relations, and treasurer at Catalent, Inc. Mr. Castellano joined Catalent in 2008 when the company formed its Financial Planning and Analysis (FP&A) group and played a role in building out its financial operations.

Prior to joining the company, Mr. Castellano worked with the Capital Markets Finance group at Lehman Brothers, where he held roles of increasing responsibility. He began his career at Cendant Corp. as part of its Financial Leadership Development Program and was later promoted into the FP&A group of its Real Estate Division.

“We are very pleased that Tom will now lead our investor relations efforts,” said John Chiminski, president and chief executive officer of Catalent. “During his years with Catalent, he has played a critical role in the Company’s transformational journey and in our July 2014 initial public offering. His expertise in financial leadership and capital markets, as well as his profound knowledge of Catalent’s operations, will be invaluable in building relationships with Wall Street and our shareholders.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters